Application no. and date | 18705097.6 (espacenet) (Federated) (European Patent Register), 20180129 | Patent/reg. no. and date | DK/EP 3494116, 20191023 | Publication date | 20190612 | Priority no. and date | US 201762451971 P, 20170130, US 201762523695 P, 20170622, US 201762560304 P, 20170919, US 201762592485 P, 20171130 | EP pub. no. and date |
EP 3494116 20190612 | Effective date | | Applicant/owner | Astrazeneca, AB
151 85 Södertälje, SE | Applicant ref. no. | 1512455 | Inventor | NISSINK, Johannes, Wilhelmus, Maria, AstraZeneca Darwin Building, Cambridge Science Park Milton Road
Cambridge, Cambridgeshire CB4 0WG, GB, BARLAAM, Bernard, Christophe, AstraZeneca, Darwin Building, Cambridge Science Park Milton Road
Cambridge, Cambridgeshire CB4 0WG, GB, SCOTT, James, Stewart, AstraZeneca, Darwin Building Cambridge Science Park Milton Road
Cambridgeshire CB4 0WG, GB, HUGHES, Samantha, Jayne, AstraZeneca, Darwin Building, Cambridge Science Park Milton Road
Cambridge, Cambridgeshire CB4 0WG, GB, YANG, Bin, AstraZeneca, 35 Gatehouse Drive
Waltham, MA 02451, US, MOSS, Thomas, Andrew, AstraZeneca, Darwin Building, Cambridge Science Park Milton Road,
Cambridgeshire CB4 0WG, GB | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/437 (2006.01) , A61K 31/501 (2006.01) , A61K 31/506 (2006.01) , A61P 35/00 (2006.01) , C07D 471/04 (2006.01) | Title | ØSTROGENRECEPTORMODULATORER | Int. application no. | EP2018052040 | Int. publication no. | WO2018138303 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|